Deka Bank Deutsche Girozentrale Bluebird Bio, Inc. Transaction History

Deka Bank Deutsche Girozentrale

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$8.96 - $16.31 $239,500 - $435,966	-26,730 Closed	0 $0
Q3 2021 Oct 22, 2021	SELL	$11.24 - $21.0 $32,596 - $60,900	-2,900 Reduced 9.79%	26,730 $513,000
Q1 2021 Apr 28, 2021	BUY	$16.59 - $33.89 $48,111 - $98,281	2,900 Added 10.85%	29,630 $850,000
Q4 2020 Mar 12, 2021	SELL	$27.5 - $37.92 $35,750 - $49,296	-1,300 Reduced 4.64%	26,730 $1.17 Million
Q3 2020 Oct 29, 2020	BUY	$34.44 - $43.75 $965,353 - $1.23 Million	28,030 New	28,030 $1.53 Million
Q1 2020 May 14, 2020	SELL	$26.16 - $63.5 $31,496 - $76,454	-1,204 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$46.96 - $61.67 $56,539 - $74,250	1,204 New	1,204 $106,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.